<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Capai Plc — News on 6ix</title>
<link>https://6ix.com/company/capai-plc</link>
<description>Latest news and press releases for Capai Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 15:19:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/capai-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57c06beedb30cb6f88e36.webp</url>
<title>Capai Plc</title>
<link>https://6ix.com/company/capai-plc</link>
</image>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/capai-plc/news/result-of-agm-1131</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/result-of-agm-1131</guid>
<pubDate>Tue, 21 Apr 2026 15:19:00 GMT</pubDate>
<description>capAI plc announced that all resolutions presented at its Annual General Meeting on April 21, 2026, were passed by a poll vote. Key resolutions included the approval of the 2025 Annual Report with 119,960,701 votes in favour (99.02%) and the Directors' Remuneration Report with 119,053,512 votes in favour (98.28%). The appointment and reappointment of directors, including John (Jack) Frame Allardyce, Sarah Jane Davy, Professor Ronjon Nag, and Marcus Yeoman, were also approved with strong majoriti</description>
</item>
<item>
<title>Notice of AGM</title>
<link>https://6ix.com/company/capai-plc/news/notice-of-agm-615</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/notice-of-agm-615</guid>
<pubDate>Fri, 27 Mar 2026 17:08:00 GMT</pubDate>
<description>capAI plc has announced that its notice of the 2026 Annual General Meeting has been sent to shareholders and is available on the company's website. The AGM will take place on April 21, 2026, at 3:00 p.m. London time, with all voting conducted via poll, requiring shareholders to submit proxy forms promptly. The 2025 Annual Report, Notice of AGM, and proxy form have also been submitted to the FCA's National Storage Mechanism for inspection.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/capai-plc/news/total-voting-rights-911</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/total-voting-rights-911</guid>
<pubDate>Fri, 27 Feb 2026 12:28:00 GMT</pubDate>
<description>capAI plc has announced its total voting rights as of 27 February 2026, stating that its issued share capital consists of 421,143,063 ordinary shares, each carrying one vote. The company holds no shares in treasury, meaning the total number of voting rights is 421,143,063. This figure serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>capAI PLC to Present at the AI & Technology Virtual Investor Conference – Strategic Platform Update</title>
<link>https://6ix.com/company/capai-plc/news/capai-plc-to-present-at-the-ai-and-technology-virtual-investor-conference-strategic-platform-update</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/capai-plc-to-present-at-the-ai-and-technology-virtual-investor-conference-strategic-platform-update</guid>
<pubDate>Wed, 18 Feb 2026 14:21:00 GMT</pubDate>
<description>Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comPALO ALTO, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- capAI PLC (LSE: CPAI; OTCQB: CPIQF), a publicly listed AI-focused incubation and platform development company with operations in Palo Alto, California and the United Kingdom, today announced that Executive Director Professor Ronjon Nag will present at the AI & Technology Virtual Investor Conference hosted</description>
</item>
<item>
<title>Commercial and Strategy Update, Fundraising</title>
<link>https://6ix.com/company/capai-plc/news/commercial-and-strategy-update-fundraising</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/commercial-and-strategy-update-fundraising</guid>
<pubDate>Tue, 10 Feb 2026 07:00:00 GMT</pubDate>
<description>capAI plc announced a commercial and strategy update, detailing advancements in its preventative health subsidiary, capMedical, with longevity programs ranging from $500 to $15,000 per user, and its media subsidiary, capMedia, which is generating initial revenues from its Author42 platform and expanding its publishing pipeline. The company also revealed a concept for an AI Growth Hacking Tool to enhance customer acquisition. To support these initiatives, capAI has conditionally raised £252,500 t</description>
</item>
<item>
<title>Final Results</title>
<link>https://6ix.com/company/capai-plc/news/final-results-730</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/final-results-730</guid>
<pubDate>Fri, 30 Jan 2026 13:25:00 GMT</pubDate>
<description>capAI plc has released its annual report for the year ended 30 September 2025, detailing a strategic repositioning into an AI-focused operating and incubation platform. The company reported a total comprehensive loss of £790,529 for the year, with cash and equivalents standing at £96,444. Significant events included fundraising activities totaling £150,000 and £275,000, the incorporation of US subsidiaries capMedia, Inc. and capMedical, Inc., and the soft launch of its first AI-enabled product, </description>
</item>
<item>
<title>Board and Committee Changes</title>
<link>https://6ix.com/company/capai-plc/news/board-and-committee-changes-21</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/board-and-committee-changes-21</guid>
<pubDate>Wed, 17 Dec 2025 09:21:00 GMT</pubDate>
<description>capAI plc announced board changes with Jack Allardyce appointed as an Executive Director, replacing Richard Edwards, and Professor Ronjon Nag assuming the role of Executive Chairman. To incentivize Allardyce's appointment, the company granted him options over 8,166,667 ordinary shares with exercise prices of £0.00315 and £0.0001, totaling an aggregate value of £13,016.66, vesting on March 12, 2026. Richard Edwards will be treated as a good leaver, with accelerated vesting for two-thirds of his u</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/capai-plc/news/holdings-in-company-1211</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/holdings-in-company-1211</guid>
<pubDate>Mon, 15 Dec 2025 10:08:00 GMT</pubDate>
<description>Sir Thomas James Hewitt Skinner BT has acquired voting rights in CAPAI PLC, increasing his holding from 3% to 4.4% of the total voting rights. This acquisition, which occurred on 11 December 2025, resulted in a total of 17,328,000 voting rights being held directly. The notification was made on 15 December 2025, and Sir Thomas confirms he is not controlled by any other entity and does not control any other undertakings holding an interest in CAPAI PLC.
Disclaimer*</description>
</item>
<item>
<title>Soft Launch of Author42</title>
<link>https://6ix.com/company/capai-plc/news/soft-launch-of-author42</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/soft-launch-of-author42</guid>
<pubDate>Tue, 18 Nov 2025 07:00:00 GMT</pubDate>
<description>capAI plc has announced the soft launch of Author42, an advanced generative-AI platform developed by its U.S. subsidiary, capMedia Inc., designed to revolutionize non-fiction book creation by integrating market insights, AI scaffolding, and professional editorial workflows. Following a successful 12-week public beta, Author42 offers features such as an AI-powered book blueprint, market demand validation, author-driven drafting, and export-ready formatting, alongside CLARA42, an embedded editoria</description>
</item>
<item>
<title>Commencement of Trading on OTCQB Venture Market</title>
<link>https://6ix.com/company/capai-plc/news/commencement-of-trading-on-otcqb-venture-market-1</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/commencement-of-trading-on-otcqb-venture-market-1</guid>
<pubDate>Wed, 05 Nov 2025 07:00:00 GMT</pubDate>
<description>Commencement of Trading on OTCQB Venture Market.</description>
</item>
<item>
<title>Exercise of Warrants, TVR and Other Updates</title>
<link>https://6ix.com/company/capai-plc/news/exercise-of-warrants-tvr-and-other-updates</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/exercise-of-warrants-tvr-and-other-updates</guid>
<pubDate>Tue, 04 Nov 2025 15:06:00 GMT</pubDate>
<description>capAI plc announced the exercise of warrants for 20,500,000 new ordinary shares, generating £124,687.50, with admission to trading expected on 7 November 2025. Following this, the company's total voting rights will comprise 393,893,063 ordinary shares. Furthermore, Professor Ronjon Nag was granted 39,304,780 new conditional awards and Richard Edwards received 9,826,194 new share options, both issued under anti-dilution provisions. The company also appointed AlbR Capital Limited as its new Corpor</description>
</item>
<item>
<title>Delivery of Completion Notice for Creator42</title>
<link>https://6ix.com/company/capai-plc/news/delivery-of-completion-notice-for-creator42</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/delivery-of-completion-notice-for-creator42</guid>
<pubDate>Wed, 15 Oct 2025 06:00:00 GMT</pubDate>
<description>capAI plc announced that R42 Group, LLC has delivered the Completion Notice under the Licence and Option Agreement (LOA) for Creator42. This confirms that Creator42 has reached minimum viable product readiness and is functionally complete, making the 12-month licence period effective from October 14, 2025. The LOA grants capAI associated rights for Creator42. This milestone signifies the platform's progression from active development to readiness for commercialization, marking the culmination of</description>
</item>
<item>
<title>Move to SETS Trading Platform</title>
<link>https://6ix.com/company/capai-plc/news/move-to-sets-trading-platform-1</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/move-to-sets-trading-platform-1</guid>
<pubDate>Tue, 14 Oct 2025 06:00:00 GMT</pubDate>
<description>capAI plc announced on October 14, 2025, that trading of its ordinary shares, with a nominal value of £0.0001 each, will transition from the London Stock Exchange's SETSqx platform to the SETS trading platform, effective immediately. This move aims to enhance liquidity for investors by providing access to traditional order book trades and two-way quotes from market makers. The company's International Securities Identification Number (ISIN) GB00BV2FG348, Stock Exchange Daily Official List (SEDOL)</description>
</item>
<item>
<title>Director/PDMR and PCA Shareholdings</title>
<link>https://6ix.com/company/capai-plc/news/directorpdmr-and-pca-shareholdings-1</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/directorpdmr-and-pca-shareholdings-1</guid>
<pubDate>Wed, 08 Oct 2025 14:54:00 GMT</pubDate>
<description>On October 8, 2025, capAI plc announced transactions involving its Executive Chairman, Richard Andrew Edwards, and his spouse, Charlotte Anna Edwards. Richard Edwards sold 2,580,000 ordinary shares at £0.03 each and purchased 2,580,000 ordinary shares at £0.030011 each within his ISA. He also gifted 7,500,000 ordinary shares to Charlotte Edwards. Charlotte Edwards sold 7,050,000 ordinary shares at £0.03 and purchased 7,050,000 ordinary shares at £0.03001 in her ISA. Following these transactions,</description>
</item>
<item>
<title>Incorporation of capMedical Inc and Other Updates</title>
<link>https://6ix.com/company/capai-plc/news/incorporation-of-capmedical-inc-and-other-updates</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/incorporation-of-capmedical-inc-and-other-updates</guid>
<pubDate>Tue, 07 Oct 2025 06:00:00 GMT</pubDate>
<description>capAI plc announced the incorporation of capMedical Inc, a wholly-owned US subsidiary in Delaware, to focus on AI-driven medical and longevity initiatives, mirroring the structure of its media-focused US subsidiary, capMedia Inc. The company intends to apply for an operational license for capMedical Inc in California to serve as the primary US operating vehicle for medical, scientific, and longevity-focused activities, with further state registrations planned as needed. Additionally, capAI has r</description>
</item>
<item>
<title>Results of GM, Share Consolidation and TVR</title>
<link>https://6ix.com/company/capai-plc/news/results-of-gm-share-consolidation-and-tvr</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/results-of-gm-share-consolidation-and-tvr</guid>
<pubDate>Mon, 06 Oct 2025 16:10:00 GMT</pubDate>
<description>CapAI plc announced that all resolutions proposed in the circular dated September 17, 2025, were passed at the General Meeting on October 6, 2025. The resolutions included approval for the allotment and issue of consideration shares and UCLNs for Author42, Creator42 and Game42 with over 99% votes in favour. A share consolidation was also approved with 99.05% votes in favour. Application has been made for the 373,393,063 New Ordinary Shares resulting from the Share Consolidation to be admitted to</description>
</item>
<item>
<title>Notice of GM</title>
<link>https://6ix.com/company/capai-plc/news/notice-of-gm-88</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/notice-of-gm-88</guid>
<pubDate>Wed, 17 Sep 2025 06:00:00 GMT</pubDate>
<description>capAI plc announced the publication of a circular regarding proposed substantial property transactions, a share consolidation, new articles of association, and a notice of a General Meeting to be held on October 6, 2025. Resolutions include approving the potential exercise of options to acquire full ownership of intellectual property related to Author42, Creator42, and Game42. A share consolidation will occur on a 10:1 basis, reducing the number of existing ordinary shares, of which there are 3,</description>
</item>
<item>
<title>capMedia Inc Hires AI Innovator</title>
<link>https://6ix.com/company/capai-plc/news/capmedia-inc-hires-ai-innovator</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/capmedia-inc-hires-ai-innovator</guid>
<pubDate>Fri, 05 Sep 2025 06:00:00 GMT</pubDate>
<description>capAI plc announced the hiring of Jayne Lytel as AI Architect at its subsidiary, capMedia Inc. Jayne, an AI Fellow at the R42 Institute, will lead the design and development of AI architecture for capMedia's creative platforms: Author42, Creator42, and Game42. This appointment marks the beginning of a build-out of up to four hires in engineering, growth, and partnerships to accelerate commercialization. Jayne will focus on optimizing AI systems and enabling pathways from book creation to cinemat</description>
</item>
<item>
<title>Exercise of Warrants</title>
<link>https://6ix.com/company/capai-plc/news/exercise-of-warrants-90</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/exercise-of-warrants-90</guid>
<pubDate>Thu, 04 Sep 2025 17:01:00 GMT</pubDate>
<description>capAI plc announced the exercise of warrants to subscribe for 102,100,000 new ordinary shares, each with a nominal value of £0.00001. The company received £70,162.50 in total consideration from this exercise. Application has been made for these new ordinary shares to be admitted to the FCA's Official List and to trading on the London Stock Exchange, with Admission expected to occur on September 9, 2025. Upon Admission, the company's issued share capital will consist of 3,733,930,636 ordinary sha</description>
</item>
<item>
<title>Licence and Option Agreement for Game42</title>
<link>https://6ix.com/company/capai-plc/news/licence-and-option-agreement-for-game42</link>
<guid isPermaLink="true">https://6ix.com/company/capai-plc/news/licence-and-option-agreement-for-game42</guid>
<pubDate>Tue, 02 Sep 2025 06:30:00 GMT</pubDate>
<description>capAI plc has executed a definitive Licence and Option Agreement with R42 Group LLC for Game42, an AI platform converting written content into games. The agreement grants capAI exclusive worldwide rights to use, develop, and commercialize Game42 for 12 months, commencing upon delivery of a Completion Notice, expected by December 31, 2025. If the Completion Notice isn't delivered by June 30, 2026, either party can terminate the agreement. capAI holds a discretionary option to acquire full Game42 </description>
</item>
</channel>
</rss>